|
News Releases
News Releases 2012
2012-11-1 Princeton Research: Money Info Show, November 1, 2012, Interview with Grant Walsh, Chairman of Medifocus, Inc.
2012-10-22 Medifocus Inc. to Attend the 23rd Video Urology World Congress in Hong Kong on November 9-11: Sees Tremendous Opportunity in Asia for the Marketing of Prolieve(R)
2012-10-15 Medifocus Inc. Chairman Grant Walsh Interviewed on the Stock Legends Radio Show
2012-10-10 Cohen Independent Research Initiates Coverage on Medifocus Inc. With a Strong Buy Recommendation
2012-10-10 Cohen Independent Research Report on Medifocus, Inc.
2012-10-9 Medifocus Inc. Retains Consulting for Strategic Growth to Implement a Strategic Investor Relations & Public Relations Program
2012-10-4 Medifocus Inc. to Attend Two Upcoming Regional American Urological Association (AUA) Meetings to Promote the Prolieve(R) Device System
2012-09-27 Medifocus Inc. Announces Update on the Prolieve(R) Acquisition and the Hiring of the Prolieve(R) Management Team
2012-09-24 S&P Capital IQ Initiates Coverage on Medifocus, Inc. in Standard & Poor's Factual Stock Reports
2012-07-25 Medifocus Inc. Completes Purchase of Prolieve(R) for the Treatment of Benign Prostatic Hyperplasia (BPH)
2012-06-26 Medifocus Announces Acquisition of Prolieve(R) Device for Treatment of Benign Prostatic Hyperplasia from Boston Scientific
2012-06-21 Medifocus Inc. Announces Closing of Private Placement Medifocus Inc.
News Releases 2011
2011-12-23 Medifocus Inc. Announces Revocation of Cease Trade Orders
2011-07-19 Medifocus Inc. Announces First Two Clinical Sites Initiated to Begin Phase III Breast Cancer Treatment Study
2011-06-30 Medifocus Inc. to Commence Trading on the United States' OTCQX on Thursday June 30, 2011
2011-06-03 Medifocus Inc. Announces Institutional Review Board (IRB) Approval for Second USA Site for Its Phase III Pivotal Breast Cancer Treatment Study
2011-04-08 Medifocus Inc. Announces Closing of Private Placement and Stock Options and Securities Grants
2011-03-30 Medifocus Inc. is Pleased to Announce the Appointment of Ernie Eves, QC, to the Board of Directors
2011-03-21 Medifocus Inc. Announces, Its Company Information Has Been Accepted To Be Available Through Standard & Poor's Market Access Program, A Recognized Securities Manual for Secondary Trading in up to 38 States under their Blue Sky Laws
2011-03-07 Medifocus Inc. Announces Units Offering
2011-03-03 Medifocus Inc. to Present Two Posters; on Positive Clinical Results of Two Studies for the Treatment of Early-Stage and Large Breast Tumors, and an Update of Phase III Clinical Study for Large Breast Tumors.
News Releases 2010
2010-10-20 Medifocus, Inc. Announces Institutional Review Board (IRB) Approval for Its Phase III Pivotal Breast Cancer Treatment Study
2010-10-18 Medifocus, Inc. Obtains Two Patents, One for the Treatment and Prevention of Breast Cancer and the Other for the Treatment of Deep Seated Tumors
2010-10-12 Medifocus, Inc. Announces, Its Breast Cancer Treatment Technology is the Feature Article in the Recent Missile Defense Agency's TechUpdate
2010-08-10 Medifocus Inc. Announces Closing of Private Placement
2010-05-13 Medifocus Inc. Announces That It Has Received Approval for Its Amended Phase III Clinical Trial for Treatment of Breast Cancer from Health Canada
2010-03-17 Medifocus, Inc. Announces Acceptance at Two Medical Society Meetings: Posters and Oral Presentations on Past Clinical Trial Results and the Upcoming Phase III Pivotal Study will be Given
2010-03-09 Medifocus, Inc. Announces That It Has Received Approval to Initiate Its Pivotal Phase III Clinical Trial for Treatment of Breast Cancer from the Food and Drug Administration (FDA), Investigational Device Exemption (IDE) Application
2010-03-05 Medifocus, Inc. announces progress Conference Call pertaining to I.D.E. application to the FDA to initiate pivotal Phase-3 trials for Microwave Breast Cancer Treatments on Tuesday 3/9/2010 at 10 am EST
2010-01-26 Medifocus, Inc. Announces Food and Drug Administration (FDA) Update for Its Pivotal Phase III Clinical Trial for Treatment of Breast Cancer : Files Response to Two Remaining Questions
2010-01-20 Medifocus, Inc. Announces Its Breast Cancer Treatment is Getting Nationwide Coverage after Positive Clinical Results Published in Annals of Surgical Oncology: Results Indicate Potentially Reducing the Need for Mastectomy
2010-01-12 Medifocus, Inc. Announces Positive Clinical Results of Its Breast Cancer Treatment Studies Published in Annals of Surgical Oncology: Planning to Begin Phase III In Early 2010
News Releases 2009
2009-12-09 Medifocus, Inc. Begins Trading on the Over The Counter (OTC)
2009-09-17 Medifocus, Inc. Files Response to Its Investigational Device Exemption (IDE) With The Food and Drug Administration (FDA) In The United States For Its Pivotal Phase III Clinical Trial For Treatment Of Breast Cancer
2009-08-13 Medifocus Provides First Default Status Report
2009-07-30 Medifocus Announces Expected Delay In Filing Annual Financial Statements
2009-06-15 Medifocus, Inc. Files an Investigational Device Exemption (IDE) with The Food And Drug Administration (FDA) in The United States For Its Pivotal Phase III Clinical Trial for Treatment Of Breast Cancer Using Its Proprietary APA System
2009-06-09 Medifocus, Inc. receives Authorization Approval from Health Canada to launch its pivotal Phase III clinical study of focused microwave heating for treatment of breast cancer in Canada
2009-04-14 Medifocus Inc. Reports Improved Clinical Efficacy for its Phase II, Randomized Clinical Study for the Treatment of Early Stage Breast Cancer Tumors
2009-04-08 Medifocus Inc. Reports Improved Clinical Efficacy for its Phase II, Randomized Clinical Study for the Treatment of Large Breast Cancer Tumors
2009-04-01 MEDIFOCUS INC. ANNOUNCES NEW DIRECTOR
News Releases 2008
2008-11-26 MEDIFOCUS INC. ANNOUNCES COMPLETION OF QUALIFYING TRANSACTION WITH CELSION (CANADA) LIMITED AND PRIVATE PLACEMENT OF UNITS
|
|
